Aqueous pharmaceutical formulations of ERbeta selective ligands

摘要

The present invention relates to aqueous formulations of ERbeta selective ligands. In some embodiments, the formulations include an ERbeta selective ligand, a solubilizer/complexant component, and a pH adjusting component. The invention further provides preparations of the formulations, and uses thereof.